Catherine Dunand, President of Cemag Invest, invests in minority growth stakes in healthcare (specifically medtech and artificial. See contact routes.
Catherine Dunand, President of Cemag Invest, invests in minority growth stakes in healthcare (specifically medtech and artificial intelligence), B2B services, and industrial technology across Europe, targeting companies from seed to Series C stages. Her distinctive thesis focuses on technology-oriented healthcare SMEs, with a particular emphasis on AI and digital health ventures. Notable portfolio companies include Diabeloop (where she serves as Chairman), Wandercraft, Aryballe, Avicenna-AI, and Faber Novel. While specific check sizes are not publicly detailed, the firm has participated in rounds totaling up to €15 million, such as Wandercraft’s Series B.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Paris.
Investors like Catherine Dunand · Full investor directory · Investor access · Company funding database